RICCARDO, FEDERICA

RICCARDO, FEDERICA  

BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE  

Mostra records
Risultati 1 - 20 di 38 (tempo di esecuzione: 0.028 secondi).
Titolo Data di pubblicazione Autore(i) File
A better immune reaction to Erbb-2 2010 Quaglino E; Mastini C; Riccardo F; Ercole E; Montani M; Forni G; Cavallo F
Antigen mimicry as an effective strategy to induce CSPG4-targeted immunity in dogs with oral melanoma: a veterinary trial 2022 Riccardo, Federica; Tarone, Lidia; Camerino, Mariateresa; Giacobino, Davide; Iussich, Selina; Barutello, Giuseppina; Arigoni, Maddalena; Conti, Laura; Bolli, Elisabetta; Quaglino, Elena; Merighi, Irene Fiore; Morello, Emanuela; Dentini, Alfredo; Ferrone, Soldano; Buracco, Paolo; Cavallo, Federica
Antitumor immunization of mothers delays tumor development in cancer-prone offspring 2015 Barutello, Giuseppina; Curcio, Claudia; Spadaro, Michela; Arigoni, Maddalena; Trovato, Rosalinda; Bolli, Elisabetta; Zheng, Yujuan; Ria, Francesco; Quaglino, Elena; Iezzi, Manuela; Riccardo, Federica; Holmgren, Lars; Forni, Guido; Cavallo, Federica
Canine Melanoma Immunology and Immunotherapy: Relevance of Translational Research 2022 Tarone L.; Giacobino D.; Camerino M.; Ferrone S.; Buracco P.; Cavallo F.; Riccardo F.
Characterization of a genetic mouse model of lung cancer: a promise to identify Non-Small Cell Lung Cancer therapeutic targets and biomarkers. 2014 Riccardo F;Arigoni M;Buson G;Zago E;Iezzi M;Longo D;Carrara M;Fiore A;Nuzzo S;Bicciato S;Nanni P;Landuzzi L;Cavallo F;Calogero R;Quaglino E
Chimeric DNA Vaccines: An Effective Way to Overcome Immune Tolerance. 2017 F. Riccardo;E. Bolli;M. Macagno;M. Arigoni;F. Cavallo;E. Quaglino
CSPG4-specific immunity and survival prolongation in dogs with oral malignant melanoma immunized with human CSPG4 DNA 2014 F. Riccardo; S. Iussich; L. Maniscalco; S. Lorda Mayayo; G. L. Rosa; M. Arigoni; R. De Maria; F. Gattino; S. Lanzardo; E. Lardone; M. Martano; E. Morello; S. Prestigio; A. Fiore; E. Quaglino; S. Zabarino; S. Ferrone; P. Buracco; F. Cavallo
CSPG4: a prototype oncoantigen for translational immunotherapy studies 2017 Rolih, Valeria; Barutello, Giuseppina; Iussich, Selina; De Maria, Raffaella; Quaglino, Elena; Buracco, Paolo; Cavallo, Federica; Riccardo, Federica
Development of a vlp-based vaccine displaying an XCT extracellular domain for the treatment of metastatic breast cancer 2020 Rolih V.; Caldeira J.; Bolli E.; Salameh A.; Conti L.; Barutello G.; Riccardo F.; Magri J.; Lamolinara A.; Parra K.; Valenzuela P.; Francia G.; Iezzi M.; Pericle F.; Cavallo F.
Difference in outcome between curative intent vs marginal excision as a first treatment in dogs with oral malignant melanoma and the impact of adjuvant CSPG4-DNA electrovaccination: A retrospective study on 155 cases 2021 Giacobino D.; Camerino M.; Riccardo F.; Cavallo F.; Tarone L.; Martano M.; Dentini A.; Iussich S.; Lardone E.; Franci P.; Valazza A.; Manassero L.; Del Magno S.; De Maria R.; Morello E.; Buracco P.
Difference in outcome between curative intent vs marginal excision as a first treatment in dogs with oral malignant melanoma and the impact of adjuvant CSPG4-DNA electrovaccination: A retrospective study on 155 cases 2021 Giacobino D.; Camerino M.; Riccardo F.; Cavallo F.; Tarone L.; Martano M.; Dentini A.; Iussich S.; Lardone E.; Franci P.; Valazza A.; Manassero L.; Del Magno S.; De Maria R.; Morello E.; Buracco P.
DNA vaccines against ErbB2+ Carcinomas: from mice to humans. 2011 Quaglino E; Riccardo F; Macagno M; Bandini S; Cojoca R; Ercole E; Amici A; Cavallo F.
Evaluation of prognostic impact of pre‐treatment neutrophil to lymphocyte and lymphocyte to monocyte ratios in dogs with oral malignant melanoma treated with surgery and adjuvant CSPG4‐antigen electrovaccination: an explorative study 2021 Mariateresa Camerino, Davide Giacobino, Selina Iussich, Ugo Ala, Federica Riccardo, Federica Cavallo, Marina Martano, Emanuela Morello, Paolo Buracco
Fighting breast cancer stem cells through the immune-targeting of the xCT cystine–glutamate antiporter 2019 Ruiu, Roberto*; Rolih, Valeria; Bolli, Elisabetta; Barutello, Giuseppina; Riccardo, Federica; Quaglino, Elena; Merighi, Irene Fiore; Pericle, Federica; Donofrio, Gaetano; Cavallo, Federica; Conti, Laura
HER2-based recombinant immunogen to target DCs through FcγRs for cancer immunotherapy. 2011 Zizzari IG; Veglia F; Taurino F; Rahimi H; Quaglino E; Belleudi F; Riccardo F; Antonilli M; Napoletano C; Bellati F; Benedetti-Panici P; Torrisi MR; Frati L; Nuti M; Rughetti A.
Identification of CSPG4 as a promising target for translational combinatorial approaches in osteosarcoma 2019 Riccardo F, Tarone L, Iussich S, Giacobino D, Arigoni M, Sammartano F, Morello E, Martano M, Gattino F, De Maria R., Ferrone S, Buracco P, Cavallo F.
Identification of Teneurin 4 as a novel cancer-stem cell associated antigen and potential biomarker. 2021 Peppino G., Barutello G., Ruiu R., Arigoni M., Riccardo F., Conti L., Calogero R.A., Quaglino E.
Identification of TENM4 as a novel cancer stem cell-associated molecule and potential target in triple negative breast cancer 2021 Ruiu R.; Barutello G.; Arigoni M.; Riccardo F.; Conti L.; Peppino G.; Annaratone L.; Marchio C.; Mengozzi G.; Calogero R.A.; Cavallo F.; Quaglino E.
Immunization against ROS1 by DNA electroporation impairs K-ras-driven lung adenocarcinomas 2020 Riccardo F.; Barutello G.; Petito A.; Tarone L.; Conti L.; Arigoni M.; Musiu C.; Izzo S.; Volante M.; Longo D.L.; Merighi I.F.; Papotti M.; Cavallo F.; Quaglino E.
Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer 2020 Conti L.; Bolli E.; Di Lorenzo A.; Franceschi V.; Macchi F.; Riccardo F.; Ruiu R.; Russo L.; Quaglino E.; Donofrio G.; Cavallo F.